Fluorometholone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SV0CSG527L, chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)- but generally known as fluorometholone, which bears US NIH Compound Identifier 3384. European Medicines Agency schedules Fluorometholone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07720MIG. The term FLUOROMETHOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules fluorometholone in its Anatomical Therapeutic Chemical (ATC) Classification. FLUOROMETHOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluorometholone under HS 29372200 and SITC 54153. As of Q4 2014, FLUOROMETHOLONE remains the US FDA Preferred Term for this commodity. Fluorometholone bears US NLM identifiers UMLS ID C0016351 and NCI Concept Code C29058. SMILES: FC12C(C3C(C(O)(CC3)C(=O)C)(CC1O)C)CC(C1=CC(=O)C=CC21C)C.